Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+80.7%
5Y CAGR+80.9%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+80.7%/yr
vs +184.6%/yr prior
5Y CAGR
+80.9%/yr
Consistent
Acceleration
-103.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
19.4x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$522.33M+72.1%
2024$303.52M+89.0%
2023$160.60M+81.4%
2022$88.53M+28.0%
2021$69.18M+156.4%
2020$26.98M+527.8%
2019$4.30M+218.4%
2018$1.35M-